CTRI/2021/09/036230
Not yet recruiting
Phase 4
Effectiveness and safety of topical autologous platelet-rich-fibrin-membrane with total-contact-castversus perilesional injectable autologous platelet-rich-plasma therapy with total-contact-cast introphic ulcer due to leprosy: randomised-controlled-trial
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Health Condition 1: L896- Pressure ulcer of heel
- Sponsor
- BANKURA SAMMILANI MEDICAL COLLEGE
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Age more than 18 years up to 80 years.
- •2\. Leprosy patients who are treatment\-naive for leg ulcer of either sex.
- •3\. Clinically diagnosed trophic ulcer due to leprosy located on the plantar, medial, or lateral aspect of the foot (including all toe surfaces); and wound area (length x width) measurement \<10 cm2\.
Exclusion Criteria
- •1\. Pregnant and lactating women.
- •2\. Patients with clinically diagnosed arterial or venous ulcer on the
- •leg or foot.
- •3\. Concomitant immune defect, heart disease, renal failure,
- •malignancy.
- •4\. Patients with psychiatric disorders.
- •5\. Participation in any clinical trial in last 3 months.
- •6\. Non\-consenting patients.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 3
Autologous platelet rich plasma in dry eye diseaseCTRI/2021/03/031887Department of ophthalmology
Recruiting
Not Applicable
Study on the safety and efficacy of autologous platelet-rich plasma (PRP) in treatment of male post prostatectomy urinary incontinencepost prostatectomy urinary incontinenceJPRN-jRCTc030230395Abe Hirokazu40
Recruiting
Not Applicable
Study on the safety and efficacy of autologous platelet-rich plasma (PRP) in treatment of female stress urinary incontinenceJPRN-jRCTc030230394Abe Hirokazu40
Recruiting
Phase 1
The safety and efficacy of autologous peripheral blood mononuclear cell ex vivo culture amplified cells (MNC-QQ) for alopecia: Phase 1 / 2 clinical studyJPRN-jRCTb030230286Ikeda Yoshio5
Completed
Not Applicable
Evaluation of clinical efficacy of autologous plasma therapy for the patients with recalcitrant atopic dermatitis and identification of plasma fraction mediating therapeutic efficacyDiseases of the blood and blood -forming organs and certain disorders involving the immune mechanismKCT0000453Ajou University Hospital36